Phil

Phil, Inc. is a patient access platform based in San Francisco, founded in 2015 by CEO Deepak Thomas. The company aims to simplify access to specialty medications, medical devices, and biologics, inspired by Thomas's personal experiences with the U.S. healthcare system. Phil has raised $126.1 million in funding and operates at the Series D stage. The platform offers streamlined prescription management, including refill coordination, medication history tracking, and notifications for upcoming refills. It integrates with a national dispense network to support patients and providers, focusing on improving adherence and reducing administrative burdens. Phil collaborates with major pharmaceutical manufacturers, such as Bausch Health and Teva Pharmaceuticals USA Inc., to enhance access to complex therapies for individuals in need. The company employs between 201 and 500 staff and is dedicated to reducing barriers in specialty medication access.